New York – September 21, 2026 -- Infrastructure Capital Advisors has expanded its SPYC exchange-traded fund into Europe, securing listings on the London Stock Exchange, Deutsche Börse Xetra and Borsa Italiana while registering the product across 11 European markets.

Southlake, Texas – September 20, 2026 -- Sabre Corporation (NASDAQ: SABR) has moved nearly 80 customers into piloting or full production on its Model Context Protocol (MCP) server, a year after launching the technology that lets AI agents book, sell and service travel directly on the company's data and inventory.

Benguerir, Morocco – September 20, 2026 -- Envision Energy has energised Morocco's first large-scale lithium iron phosphate battery storage system, a 25 MW / 125 MWh unit installed at OCP Green Energy's Benguerir mining site.

Hong Kong – September 20, 2026 -- Reap has launched Sentry, a managed fraud and risk service that eliminates the need for card-issuing clients to build in-house fraud teams or license separate monitoring tools.

Seoul – September 20, 2026 -- LG Display has begun mass production of a 24.5-inch Gaming OLED panel with a 720Hz refresh rate, the highest ever achieved in a gaming OLED display, alongside a 0.02ms response time.

Seattle – September 20, 2026 -- Convera and JustLogin have partnered to embed regulated cross-border payroll and business payment capabilities directly into JustLogin's HR platform, enabling companies to initiate payments in up to 16 currencies across Singapore and Southeast Asia.

Houston and Oxford – September 20, 2026 -- Velocys has released the AlphaCore 800, its highest-capacity microchannel Fischer-Tropsch reactor to date, capable of producing up to 800 barrels per day, or 30,000 tonnes per year, from a single unit.

Shanghai – September 20, 2026 -- Antengene Corporation Limited (SEHK: 6996.HK) has dosed the first patient in China in its pivotal Phase III CLINCH-3 study evaluating ATG-022, a CLDN18.2 antibody-drug conjugate, as monotherapy for CLDN18.2-positive advanced gastric or gastroesophageal junction adenocarcinoma.

Atlanta – September 20, 2026 -- Siemba has launched automated testing for insecure direct object reference (IDOR) flaws, cutting the time to scan a 200-endpoint API collection to under an hour, a task the company says has typically taken human testers days or weeks.

New York and Suzhou, China – September 20, 2026 -- Accro Bioscience Inc. has dosed its first patient in a Phase IIb trial testing AC-101, a selective RIPK2 inhibitor, in patients with moderate-to-severe ulcerative colitis (UC).